NCT05593523View on ClinicalTrials.gov

Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Burn Wound
Interventions
DRUG

Indocyanine green (ICG)

ICG is a well, known, FDA-approved dye

DEVICE

Clinical Fluorescence Imaging Device

OnLume Clinical Imaging System or Commercially-available FDA approved clinical fluorescence imaging device (SPY Elite fluorescence imaging system, SPY-PHI portable handheld imaging system, or EleVision IR platform (also known as VS3-IR system)

Trial Locations (1)

53792

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Wisconsin, Madison

OTHER